Welcome to Dwaey, specifically on Perindopril Erbumine page.
This medicine contains important and useful components, as it consists of
Perindopril Erbumine is available in the market in concentration.
Perindopril Erbumine
Before starting treatment with perindopril erbumine, it is crucial to consult a healthcare provider to ensure safe and appropriate use. Key precautions to be aware of include:
- Renal Impairment: Perindopril should be used with caution in patients with renal impairment. Regular monitoring of kidney function (serum creatinine and blood urea nitrogen) is necessary, as perindopril can worsen renal function in patients with pre-existing kidney disease.
- Hypotension and Volume Depletion: In patients who are volume-depleted, such as those on diuretics or those who are dehydrated, perindopril may cause a significant drop in blood pressure. Close monitoring of blood pressure is required, and the dose of diuretics may need to be adjusted when initiating therapy.
- Electrolyte Imbalances: Perindopril may increase potassium levels, leading to hyperkalemia, especially in patients with renal impairment or those taking potassium-sparing diuretics or potassium supplements. Serum potassium levels should be monitored regularly.
- Pregnancy and Breastfeeding: Perindopril is contraindicated during pregnancy, particularly in the second and third trimesters, due to the risk of fetal harm, such as renal failure, hypotension, and developmental abnormalities. It is not recommended during breastfeeding, as it may pass into breast milk and harm the infant.
- Angioedema: Patients with a history of angioedema (swelling of the face, lips, throat, or tongue) related to ACE inhibitors or other drugs should not use perindopril. If angioedema develops during treatment, it requires immediate discontinuation of the drug and emergency medical attention.
- Hepatic Impairment: Caution is advised in patients with severe hepatic impairment, as perindopril may exacerbate liver dysfunction. Liver function tests should be monitored during treatment.
Perindopril erbumine is primarily used for the treatment of cardiovascular conditions, including:
- Hypertension (High Blood Pressure): Perindopril is used to manage high blood pressure in adults, reducing the risk of complications such as heart attack, stroke, and kidney disease.
- Chronic Heart Failure: Perindopril is used in the management of chronic heart failure to help improve symptoms, reduce hospitalizations, and improve overall survival in patients with left ventricular dysfunction.
- Prevention of Stroke and Cardiovascular Events: It may also be used in patients at high risk for cardiovascular events, such as those with a history of coronary artery disease, to prevent heart attacks and strokes.
- Post-Myocardial Infarction: After a heart attack, perindopril may be prescribed to improve survival and reduce the risk of further cardiac events.
Perindopril erbumine is contraindicated in certain situations to ensure patient safety:
- Pregnancy: It is contraindicated during pregnancy, particularly in the second and third trimesters, due to the risk of fetal injury, including renal failure and death.
- Angioedema: A history of angioedema (swelling of the throat, face, or tongue) related to previous ACE inhibitor therapy or other medications is a contraindication for using perindopril.
- Bilateral Renal Artery Stenosis: Perindopril should be avoided in patients with bilateral renal artery stenosis (narrowing of the arteries that supply the kidneys), as it can exacerbate kidney dysfunction.
- Severe Renal Impairment: Contraindicated in patients with severe renal impairment (creatinine clearance <30 mL/min), as perindopril can worsen kidney function.
- Hypersensitivity: Any history of hypersensitivity to perindopril, other ACE inhibitors, or any of the excipients in the formulation should prompt the patient to avoid this medication.
Perindopril erbumine may cause a range of side effects, from mild to severe. Common and serious side effects include:
- Common Side Effects:
- Dizziness or lightheadedness, especially when standing up quickly
- Fatigue or weakness
- Headache
- Nausea or upset stomach
- Cough (persistent dry cough is a common side effect of ACE inhibitors)
- Serious Side Effects:
- Angioedema: Swelling of the face, tongue, throat, or lips, which may lead to difficulty breathing. This is a medical emergency and requires immediate discontinuation of the drug and treatment.
- Hyperkalemia: Elevated potassium levels, which can cause muscle weakness, irregular heartbeats, or cardiac arrest. Patients should be monitored for signs of hyperkalemia.
- Severe Hypotension: A significant drop in blood pressure, especially after the first dose or in volume-depleted patients, leading to dizziness, fainting, or shock.
- Renal Dysfunction: Worsening kidney function, which may lead to acute kidney failure, especially in patients with pre-existing kidney conditions.
- Liver Toxicity: Although rare, perindopril can cause liver enzyme abnormalities and jaundice. Liver function tests should be monitored during treatment.
4
Perindopril erbumine works by inhibiting the enzyme angiotensin-converting enzyme (ACE), which is responsible for converting angiotensin I into angiotensin II. The effects of perindopril include:
- Reduction of Angiotensin II: By inhibiting ACE, perindopril reduces the levels of angiotensin II, a potent vasoconstrictor. This leads to the dilation (widening) of blood vessels, resulting in lowered blood pressure.
- Decreased Aldosterone Secretion: Angiotensin II normally stimulates the release of aldosterone, which causes the kidneys to retain sodium and water. By reducing angiotensin II levels, perindopril also lowers aldosterone levels, helping to reduce fluid retention and lower blood pressure.
- Improved Heart Function: By lowering blood pressure and reducing the workload on the heart, perindopril helps improve symptoms of heart failure and enhances the heart's pumping ability.
- Kidney Protection: Perindopril helps reduce proteinuria (protein in the urine), which is a marker of kidney damage. This protective effect is particularly important in patients with diabetes or chronic kidney disease.
Perindopril erbumine may interact with several medications, increasing the risk of side effects or altering its efficacy:
- Diuretics: Combining perindopril with diuretics, especially potassium-sparing diuretics like spironolactone, can increase the risk of hyperkalemia (elevated potassium levels) and low blood pressure (hypotension), especially when initiating treatment.
- Other Antihypertensive Medications: Perindopril may have an additive effect when combined with other antihypertensive medications, leading to excessive blood pressure lowering. Careful monitoring is required, especially during dose adjustments.
- Potassium Supplements or Potassium-Sparing Diuretics: Using perindopril in conjunction with potassium supplements or potassium-sparing diuretics (e.g., spironolactone) can increase the risk of hyperkalemia.
- Lithium: Perindopril may increase lithium levels, leading to lithium toxicity. Monitoring of serum lithium concentrations is recommended if these drugs are used together.
- NSAIDs (Nonsteroidal Anti-Inflammatory Drugs): Concurrent use of perindopril and NSAIDs may reduce the antihypertensive effect of perindopril and increase the risk of kidney impairment.
The usual starting dose for perindopril in adults is 4 mg once daily. Depending on the patient's response, the dose may be gradually increased to 8 mg once daily. The maximum recommended dose is 16 mg per day. Dosing may be adjusted for patients with renal impairment or those on diuretics:
- Hypertension: Starting dose is typically 4 mg once daily, with the possibility of increasing to 8 mg once daily for patients requiring additional blood pressure control.
- Chronic Heart Failure: The initial dose is typically 2 mg once daily, with gradual dose increases based on the patient's tolerance.
- Post-Myocardial Infarction: Starting dose may be 4 mg once daily, with adjustments as necessary.
Perindopril is not typically recommended for children under 18 years of age due to limited safety and efficacy data. In exceptional circumstances, healthcare providers may prescribe perindopril in pediatric patients, but careful dosing and monitoring are required.
---
As always, it is crucial for patients to consult their healthcare provider before starting perindopril erbumine to ensure it is the appropriate treatment for their condition and to discuss any potential risks, interactions, or necessary dose adjustments.
For patients with renal impairment, dose adjustments may be necessary:
- Mild Renal Impairment (creatinine clearance ≥60 mL/min): No dose adjustment is generally required.
- Moderate Renal Impairment (creatinine clearance 30–60 mL/min): The starting dose may be reduced to 2 mg once daily.
- Severe Renal Impairment (creatinine clearance <30 mL/min): Perindopril should be used with caution, and the dose may be further reduced. It is important to monitor kidney function regularly.